NANOBIOTIX to Participate in Investor Conferences in March

Core Viewpoint - Nanobiotix, a late-stage clinical biotechnology company, is set to participate in several upcoming healthcare conferences in March 2026, showcasing its innovative nanotherapeutic approaches for cancer and other major diseases [1][2]. Company Overview - Nanobiotix was incorporated in 2003 and is headquartered in Paris, France. It has been listed on Euronext Paris since 2012 and on the Nasdaq Global Select Market since December 2020. The company has subsidiaries in Cambridge, Massachusetts, among other locations [3]. - The company owns over 25 patent families related to three nanotechnology platforms, which have applications in oncology, bioavailability and biodistribution, and disorders of the central nervous system [3]. Upcoming Conferences - Nanobiotix will present at the following conferences: - TD Cowen's Health Care Conference on March 4, 2026, in Boston, MA, with a fireside chat at 11:10 am ET [1]. - UBS Biotech Summit on March 9, 2026, in Miami Beach, FL [2]. - Jefferies Biotech on the Beach Summit on March 10, 2026, in Miami Beach, FL [2]. - Leerink's Global Healthcare Conference on March 11, 2026, in Miami Beach, FL, with a fireside chat at 2:20 pm EDT [2]. - Presenters at these events will include Laurent Levy, CEO, and Bart van Rhijn, Chief Financial & Business Officer of Nanobiotix [1][2].